CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?

Chimeric antigen receptor (CAR) T-cell systemic immunotherapy has revolutionized how clinicians treat several refractory and relapsed hematologic malignancies. Due to its peculiar mechanism of action, CAR T-cell-based therapy has enlarged the spectrum of neurological toxicities. CAR T-cell-associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Velasco, Roser, Mussetti, Alberto, Villagrán-García, Macarena, Sureda, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117964/
https://www.ncbi.nlm.nih.gov/pubmed/37090983
http://dx.doi.org/10.3389/fneur.2023.1144414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117964/
https://www.ncbi.nlm.nih.gov/pubmed/37090983
http://dx.doi.org/10.3389/fneur.2023.1144414

Ejemplares similares